Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지

Cervical Human Papilloma Virus Infection among the General Female Population in Vietnam: A Situation Analysis

Vu, Lan T H;Le, Ha T T

  • Published : 20110200
⟨ Previous Next ⟩

Abstract

Human papilloma virus (HPV) is the necessary cause of cervical cancer. This survey used a sample of 1,500 married women aged 15-69 to examine the prevalence of HPV infection and HPV specific types in Vietnam as well as risk factors of HPV infection. Results indicated that the prevalence of HPV infection in Hanoi and HCM was 6.13 and 8.27. The proportion of multiple HPV infection was also higher in HCM than in Hanoi (35.5% vs. 17.4%). Risk factors having significant associations with general HPV infection were early age at first sexual intercourse, number of life time sexual partners and period of use of oral contraceptives. Future implementation of HPV vaccine campaigns in Vietnam should consider the fact that HPV type 58 is common among both Hanoi and HCM populations, which none of the currently available vaccines target.

Keywords

References

  1. Bosch FX (2008). Epidemiology and natural history of human papillomavirus infections and type - specific implications in cervical neoplasia. Vaccine, 26, K1-16. https://doi.org/10.1016/j.vaccine.2008.05.064
  2. Clifford GM, Smith JS, Plammer M, et al (2003). Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. BJC, 88, 63-73. https://doi.org/10.1038/sj.bjc.6600688
  3. Cooper D, Hoffman M, Carrara H, et al (2007). Determinants of sexual activity and its relation to cervical cancer risk among South African women. BMC Public Hlth, 7, 341. https://doi.org/10.1186/1471-2458-7-341
  4. Dunne EF, Unger ER, Sternberg M, et al (2007). Prevalence of HPV infection among females in the United States. JAMA, 297, 813-9. https://doi.org/10.1001/jama.297.8.813
  5. Food and Drug Administration (FDA). FDA News: FDA licenses new vaccine for prevention of cervical cancer and other diseases in females caused by human Papillomavirus.
  6. Giuliano AR, Papenfuss M, Schneider A, et al (1999). Risk factors for high- risk type human papilomavirus infection among Mexican-American women. Cancer Epidemiol Biomarkers Prev, 8, 615-20.
  7. Giuliano AR, Papenfuss M, Abrahamsen M, et al (2001). Human papillomavirus infection at the United States-Mexico border: Implications for cervical cancer prevention and controls. Cancer Epidemiol Biomarkers Prev, 10, 1129-36.
  8. Huynh ML, Raab SS, Suba EJ. Association between war and cervical cancer among Vietnamese women. Int J Cancer, 110, 775-7.
  9. Lazcano-Ponce E, Herrero R, Munoz N, et al (2001). Epidemiology of HPV infection among Mexican women with normal cervical cytology. Int J Cancer, 91, 412-20. https://doi.org/10.1002/1097-0215(20010201)91:3<412::AID-IJC1071>3.0.CO;2-M
  10. Parkin DM, Bray F, Ferlay J, et al (2001). Estimating the world cancer burden: Globocan 2000. Int J Cancer, 94, 153-6. https://doi.org/10.1002/ijc.1440
  11. Pham TH, Nguyen TH, Herrero R, et al (2001). Cancer registration in Vietnam. Asia Pac J Cancer Prev, Suppl IACR, 85-90.
  12. Pham TH, Nguyen TH, Herrero R, et al (2003). Human Papilloma Virus infection among women in south and north of Vietnam. Int J Cancer, 104, 213-20. https://doi.org/10.1002/ijc.10936
  13. Sellors JW, Karwalajtys TL, Kaczorowski J, et al (2003). Incidence, clearance and predictors of human papillomavius infection in women. CMAJ, 168, 421-5.
  14. Villa, LL, Costa RL, Petta CA, et al (2005). Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol, 6, 271-8. https://doi.org/10.1016/S1470-2045(05)70101-7
  15. Walboomers JM, Jacobs MV, Manos MM, et al (1999). Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol, 189, 12-9.